Share buy-back programs

Stock dividends, compensation plans & reducing issued capital

Share buy-back programs

It is necessary for DSM to undertake regular share buy-back programs to cover its commitment to shareholders wishing to receive their dividend in the form of ordinary shares, as well as to fulfill its obligations under share-based compensation plans.

DSM obtains approval for the company to repurchase its own shares each year at the Annual General Meeting of Shareholders. Each year we also obtain approval to reduce the company's issued capital by cancellation of its shares up to a maximum of the number that is, or will be bought by, the company.

Current program

€1 billion share buy-back and regular repurchase to cover share plans and stock dividend

With effect from 1 April 2019 DSM is repurchasing ordinary shares with an aggregate market value of €1 billion with the intention of reducing its issued capital, as first announced with the publication of the 2018 Annual Results on 14 February.

In addition, on 14 March DSM announced the intended repurchase of a further 2,600,000 ordinary shares to cover commitments under share-based compensation plans and stock dividend.

In accordance with Article 2(2) of the EU Regulation that contains technical standards for buyback programs, DSM details progress via weekly press releases. This Daily Transaction Details Share Repurchase Program zip file contains spreadsheets updated each week during the course of the program.

Press releases

Recent programs

2018: 1,100,000 shares

August to October

DSM repurchased a total of 1,100,000 shares for a combined consideration of €98.9 million in accordance with the repurchase program announced on 13 August 2018. This Daily Transaction Details 1.1m Share Repurchase Program spreadsheet was updated and published weekly during the course of the program.

2018: 1,600,000 shares

March to April & May to June

DSM repurchased a total of 1,600,000 shares for a combined consideration of €136.7 million in accordance with the repurchase program announced on 19 March 2018. This Daily Transaction Details 1.6m Share Repurchase Program spreadsheet was updated and published weekly during the course of the program.

2017: 1,600,000 shares

August - November

DSM repurchased a total of 1,600,000 shares for a combined €109.3 million in accordance with the repurchase program announced on 14 August 2017. This Daily Transaction Details 1.6m Share Repurchase Program spreadsheet was updated weekly during the course of the buy-back program.

2017: 2,900,000 shares

March - July

DSM repurchased a total of 2,900,000 shares for a combined €187.2 million in accordance with the repurchase program announced on 13 March 2017. This Daily transaction details 2.9m Share Repurchase Program spreadsheet was updated weekly during the course of the buy-back program.

2016: 1,700,000 shares

November - December

DSM repurchased a total of 1,700,000 shares for a combined €96.0 million in accordance with the repurchase program announced on 4 November 2016. This Daily Transaction Details 1.7m Share Repurchase Program spreadsheet was updated weekly during the course of the buy-back program.

2016: 3,500,000 shares

February - July

DSM repurchased a total of 3,500,000 shares for a combined €176.8 million in accordance with the repurchase program announced on 22 February 2016 (as amended on 10 June 2016). DSM informed the market about the program's progress via weekly press releases.

2015: 2,300,000 shares

May - July

DSM repurchased a total of 2,300,000 shares for a combined €122.5 million in accordance with the repurchase program announced on 14 May 2015. DSM informed the market about the program's progress via weekly press releases.

Statement pursuant to art. 5:25a of the Dutch Financial Supervision Act

DSM declares that the Netherlands is its "Home Member State", as required by article 5:25a (2) of the Dutch Financial Supervision Act. This article obliges all listed companies to publicly announce which country is their "home member state" (as referred to in article 5:25a(1) sub c of the Dutch Financial Supervision Act) for purposes of regulation of their disclosure obligations under the EU Transparency Directive. Pursuant to section 5:25a of the Dutch Financial Supervision Act, Royal DSM has notified the Dutch Authority for the Financial Markets (AFM).

Read more

This site uses cookies to store information on your computer.

Learn more